AVEO Oncology
AVEO
#7491
Rank
C$0.74 B
Marketcap
C$21.39
Share price
0.00%
Change (1 day)
175.44%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$76.06 Million a decrease over its 2020 earnings that were of -C$50.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-51.08%
2021 -C$76.06 Million49.9%
2020 -C$50.74 Million-479.04%
2019 C$13.38 M-276.17%
2018 -C$7.6 Million-91.79%
2017 -C$92.57 Million142.38%
2016 -C$38.2 Million78.51%
2015 -C$21.4 Million-71.55%
2014 -C$75.2 Million-50.72%
2013 -C$0.16 Billion-4.88%
2012 -C$0.17 Billion-426.29%
2011 C$49.16 M-159.85%
2010 -C$82.16 Million35.33%
2009 -C$60.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$49.57 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.75 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$0.63 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$8.10 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.15 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.23 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA